SPC304

Crisaboról, valkvætt á formi lyfjafræðilega viðunandi salts

  • Status:
    Veitt
  • Application date:
    26.6.2020
  • Application published:
    15.7.2020
  • Grant published:
    15.3.2021
  • Max expiry date:
    15.2.2031
  • Next due date:
    28.2.2027
  • Medicine name:
    Staquis
  • Medicine for children:
    No

Timeline

Today
26.6.2020Application
15.7.2020Publication
15.3.2021Registration
15.2.2027Expires

Marketing license

  • IS authorization number:
    EU/1/19/1421/001-004
  • Date:
    20.4.2020
  • Foreign authorization number:
    EU/1/19/1421
  • Date:
    27.3.2020

Owner

  • Name:
    Anacor Pharmaceuticals, Inc.
  • Address:
    235 East 42nd Street, New York US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 12.1.2026

Expires: 15.2.2027

Payer: Árnason Faktor ehf.

Upload documents